DHX15 and hepatocellular carcinoma: As shown in Figure 6C, patients with HCC present significant higher levels of circulating DHX15 compared to healthy subjects (300.3 ± 88.2 vs. 32.4 ± 27.7 pg/mL; p < 0.01; respectively).